News & Analysis as of

Automotive Industry › Pharmaceutical Industry › Semiconductors

Alston & Bird

U.S. and European Union Release Details of Trade Deal 

Alston & Bird on

On August 21, the White House and the European Union released a joint statement that sheds some light on aspects of the framework trade deal announced last month. The joint statement confirms the baseline 15% U.S. tariff on...more

Husch Blackwell LLP

The US and EU Reach A Trade Deal—EU Goods Subject to 15% Tariff

Husch Blackwell LLP on

On July 27, 2025, President Trump announced that the U.S. and European Union (“EU”) have reached a trade deal. Pursuant to the Fact Sheet released by the White House on July 28th, the U.S. will impose a 15% tariff on all EU...more

Baker Donelson

New Section 232 Investigations Target Pharmaceutical, Semiconductor, and Critical Mineral Industries: What Impacted Businesses...

Baker Donelson on

The Department of Commerce (Commerce) has launched three Section 232 investigations covering pharmaceuticals, pharmaceutical ingredients, and their derivative products; semiconductors and semiconductor manufacturing equipment...more

Alston & Bird

Trump Signals 25% Tariffs on Automobiles, Semiconductors, and Pharmaceuticals

Alston & Bird on

President Trump told reporters at Mar-a-Lago that he would likely announce tariffs on April 2 on imports of automobiles, semiconductors, and pharmaceuticals, starting at 25 percent. He added that such tariffs would “go very...more

Jones Day

Mexican Government Releases "Plan México"

Jones Day on

The Mexican government recently launched the Mexico Plan (Plan México), a six-year strategy in collaboration with the federal government and the private sector intended to promote economic growth in Mexico....more

Robins Kaplan LLP

Financial Daily Dose 2.4.2021 | Top Story: McKinsey to Pay $587 Million for Role in Opioid Crisis

Robins Kaplan LLP on

Consulting standard-bearer McKinsey & Co. will pay $573 million to resolve state investigations and allegations related to its role “in helping ‘turbocharge’ opioid sales, a rare instance of it being held publicly accountable...more

Robins Kaplan LLP

Financial Daily Dose 10.6.2019 | Top Story: Drug Distributors and Maker in Talks for Multi-billion-dollar Opioid Litigation...

Robins Kaplan LLP on

A group of three major drug distributors—McKesson, AmerisourceBergen, and Cardinal Health—are in the midst of talks with representatives of state and local governments who have brought more than 2000 opioid-related lawsuits...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide